Peter W. Sonsini - 19 Oct 2022 Form 4 Insider Report for AVEO PHARMACEUTICALS, INC.

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
21 Oct 2022, 16:53:29 UTC
Prior SEC filing
19 Oct 2022
Next SEC filing
18 Nov 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Louis Citron, attorney-in-fact

Key filing fact

Peter W. Sonsini filed Form 4 for AVEO PHARMACEUTICALS, INC. on 21 Oct 2022.

Key facts

  • This page summarizes Peter W. Sonsini's Form 4 filing for AVEO PHARMACEUTICALS, INC..
  • 9 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 21 Oct 2022, 16:53.

Change

  • Previous filing in this sequence was filed on 19 Oct 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AVEO transaction

Common Stock

Other

Transaction value
$0
Shares
-3,952,957
Change %
-100%
Price
$0.000000*
Shares after
0
Date
19 Oct 2022
Ownership
See Note 2
Footnotes
F1, F2
AVEO transaction

Common Stock

Other

Transaction value
$0
Shares
+3,952,957
Change %
Price
$0.000000
Shares after
3,952,957
Date
19 Oct 2022
Ownership
See Note 4
Footnotes
F3, F4
AVEO transaction

Common Stock

Other

Transaction value
$0
Shares
-3,952,957
Change %
-100%
Price
$0.000000*
Shares after
0
Date
19 Oct 2022
Ownership
See Note 4
Footnotes
F4, F5
AVEO transaction

Common Stock

Other

Transaction value
$0
Shares
+59,294
Change %
Price
$0.000000
Shares after
59,294
Date
19 Oct 2022
Ownership
See Note 7
Footnotes
F6, F7
AVEO transaction

Common Stock

Other

Transaction value
$0
Shares
-59,294
Change %
-100%
Price
$0.000000*
Shares after
0
Date
19 Oct 2022
Ownership
See Note 7
Footnotes
F7, F8
AVEO transaction

Common Stock

Other

Transaction value
$0
Shares
+1,551
Change %
Price
$0.000000
Shares after
1,551
Date
19 Oct 2022
Ownership
See Note 10
Footnotes
F9, F10
AVEO transaction

Common Stock

Other

Transaction value
$0
Shares
+24
Change %
Price
$0.000000
Shares after
24
Date
19 Oct 2022
Ownership
See Note 12
Footnotes
F11, F12
AVEO transaction

Common Stock

Other

Transaction value
$0
Shares
+24
Change %
Price
$0.000000
Shares after
24
Date
19 Oct 2022
Ownership
See Note 14
Footnotes
F13, F14
AVEO transaction

Common Stock

Other

Transaction value
$0
Shares
+24
Change %
Price
$0.000000
Shares after
24
Date
19 Oct 2022
Ownership
See Note 16
Footnotes
F15, F16
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Peter W. Sonsini is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 16 footnotes

Footnote F1

Growth Equity Opportunities Fund IV, LLC ("GEO IV") made a distribution of 3,952,957 shares of Common Stock of the Issuer to its sole member for no consideration on October 19, 2022.

Footnote F2

The Reporting Person is a manager of NEA 15 GP, LLC ("NEA 15 GP"), which is the sole general partner of NEA Partners 15, L.P. ("NEA Partners 15"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L. P. ("NEA 15"). NEA 15 is the sole member of GEO IV, the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by GEO IV in which the Reporting Person has no pecuniary interest.

Footnote F3

NEA 15 received 3,952,957 shares of Common Stock of the Issuer in the distribution made by GEO IV on October 19, 2022.

Footnote F4

The Reporting Person is a manager of NEA 15 GP, which is the sole general partner of NEA Partners 15. NEA Partners 15 is the sole general partner of NEA 15, the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 15 in which the Reporting Person has no pecuniary interest.

Footnote F5

NEA 15 made a pro rata distribution of 3,952,957 shares of Common Stock of the Issuer for no consideration to its general partner and limited partners on October 19, 2022.

Footnote F6

NEA Partners 15 received 59,294 shares of Common Stock of the Issuer in the distribution made by NEA 15 on October 19, 2022.

Footnote F7

The Reporting Person is a manager of NEA 15 GP, which is the sole general partner of NEA Partners 15, the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA Partners 15 in which the Reporting Person has no pecuniary interest.

Footnote F8

NEA Partners 15 made a pro rata distribution for no consideration of an aggregate of 59,294 shares of Common Stock of the Issuer to its limited partners on October 19, 2022.

Footnote F9

Peter W. Sonsini and Diane C. Sonsini, as trustees of the Peter & Diane Sonsini Family Trust dated January 17, 2007 (the "Sonsini Family Trust"), received 1,551 shares of Common Stock of the Issuer in the distribution by NEA Partners 15 on October 19, 2022.

Footnote F10

The Reporting Person is a trustee of the Sonsini Family Trust, which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the 1934 Act, as amended, or otherwise of such portion of the securities held by the Sonsini Family Trust in which the Reporting Person has no pecuniary interest.

Footnote F11

Peter W. Sonsini and Diane C. Sonsini, as trustees of the Elsa Katherine Sonsini Trust dated December 5, 2019 (the "Elsa Katherine Sonsini Trust"), received 24 shares of Common Stock of the Issuer in the distribution by NEA Partners 15 on October 19, 2022

Footnote F12

The Reporting Person is a trustee of the Elsa Katherine Sonsini Trust, which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the 1934 Act, as amended, or otherwise of such portion of the securities held by the Elsa Katherine Sonsini Trust in which the Reporting Person has no pecuniary interest.

Footnote F13

Peter W. Sonsini and Diane C. Sonsini, as trustees of the Jake Theodore Sonsini Trust dated December 5, 2019 (the "Jake Theodore Sonsini Trust"), received 24 shares of Common Stock of the Issuer in the distribution by NEA Partners 15 on October 19, 2022.

Footnote F14

The Reporting Person is a trustee of the Jake Theodore Sonsini Trust, which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the 1934 Act, as amended, or otherwise of such portion of the securities held by the Jake Theodore Sonsini Trust in which the Reporting Person has no pecuniary interest.

Footnote F15

Peter W. Sonsini and Diane C. Sonsini, as trustees of the Louisa Marie Sonsini Trust dated December 5, 2019 (the "Louisa Marie Sonsini Trust"), received 24 shares of Common Stock of the Issuer in the distribution by NEA Partners 15 on October 19, 2022.

Footnote F16

The Reporting Person is a trustee of the Louisa Marie Sonsini Trust, which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the 1934 Act, as amended, or otherwise of such portion of the securities held by the Louisa Marie Sonsini Trust in which the Reporting Person has no pecuniary interest.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .